Search

Author/Creator Le, Hannah

2. Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis. (2nd December 2022)

Authors:
Amin, Alpesh; Keshishian, Allison; Hines, Dionne M.; Dina, Oluwaseyi; Le, Hannah; Rosenblatt, Lisa; Liu, Xianchen; Zhang, Qisu; Vo, Lien
Journal:
Current medical research and opinion
Issue:
Volume 38:Number 12(2022)
Page Start:
2131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System. Issue 7 (7th June 2021)

Authors:
Frei, Christopher R.; Le, Hannah; McHugh, Daniel; Ryan, Kellie; Jones, Xavier; Galley, Samantha; Franklin, Kathleen; Baus, Courtney J.; Tavera, Juan; Janania-Martinez, Michelle; Gregorio, David; Ananth, Snegha; Uribe, Ricardo; Surapaneni, Prathibha; Espinoza-Gutarra, Manuel; Song, Michael M.; Ten...
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 7(2021)
Page Start:
1664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population. (2nd September 2017)

Authors:
Amin, Alpesh; Keshishian, Allison; Trocio, Jeffrey; Dina, Oluwaseyi; Le, Hannah; Rosenblatt, Lisa; Liu, Xianchen; Mardekian, Jack; Zhang, Qisu; Baser, Onur; Vo, Lien
Journal:
Current medical research and opinion
Issue:
Volume 33:Number 9(2017)
Page Start:
1595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗